CTVA Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Corteva's stock price has shown a mixed trend recently, with support around $58.72 and resistance at $62.31. The latest candlestick chart indicates a potential bullish reversal pattern, suggesting short-term upside.
Valuation Analysis:
Corteva currently has a P/E ratio of 24.1, which is in line with the average for the agricultural inputs sector. This suggests that the stock is fairly valued, with room for growth if earnings expectations are met.
Sentiment and Analyst Ratings:
Analyst sentiment is positive, with a consensus rating of "Strong Buy" and a mean price target of $70.36. Recent insider activity has been negative, with significant selling, which could indicate short-term weakness.
Conclusion:
Based on the analysis, the stock is expected to rise to $63.00 in the next trading week. The bullish technical indicators and positive analyst sentiment suggest a buy recommendation.
CTVA Similar Chart Price Prediction
The price of CTVA is predicted to go up 4.04%, based on the high correlation periods with CXE. The similarity of these two price pattern on the periods is 94.78%.
CTVA
CXE
Up: 4.04%Similarity: 94.78%
CTVA Revenue Forecast
CTVA EPS Forecast
CTVA FAQs
What is CTVA revenue forecast for next quarter？
What is CTVA eps forecast for next quarter？
CTVA VS S&P500
Corteva's profits will see a boost from the expiration of a $1 billion annual royalty payment to Bayer in 2023.
Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.
Corteva's strong pipeline of patented crop protection chemicals will drive profits and margins higher as the company expands its proportion of sales from patented and differentiated crop protection products.
CTVA Analyst's Forecast
Bill Selesky
Argus Research
Hold → Strong Buy
2025-03-31
Price Target
$69
Upside
+9.65%
Argus analyst Bill Selesky upgraded Corteva to Buy from Hold with a $69 price target.
Duffy Fischer
Goldman Sachs
Strong Buy
2025-03-13
Price Target
$71
Upside
+21.18%
Benjamin Theurer
Barclays
Hold
2025-01-21
Price Target
$62 → $64
Upside
+1.39%
